IHC analysis combined with mean optical density (MOD) showed that the expression of LPL/FABP4/CPT1 molecules increased gradually during the period of NAFLD/NASH progression to HCC (Figure 3D). The gene discussed is CPT1A; the disease is metabolic dysfunction-associated steatotic liver disease.